Cash · 2012–2025
Regenxbio cash
$34.5M−40.1% · FY2025
Regenxbio (RGNX) reported $34.5M in cash for fiscal 2025, −40.1% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $34.5M | −40.1% | Open → |
| FY20242024-12-31 | $57.5M | +66.6% | Open → |
| FY20232023-12-31 | $34.5M | −64.4% | Open → |
| FY20222022-12-31 | $97.0M | −71.9% | Open → |
| FY20212021-12-31 | $345M | +2.0% | Open → |
| FY20202020-12-31 | $338M | +386.8% | Open → |
| FY20192019-12-31 | $69.5M | −8.0% | Open → |
| FY20182018-12-31 | $75.6M | +62.0% | Open → |
| FY20172017-12-31 | $46.7M | +87.8% | Open → |
| FY20162016-12-31 | $24.8M | −54.1% | Open → |
| FY20152015-12-31 | $54.1M | +4,727.5% | Open → |
| FY20142014-12-31 | $1.1M | +0.2% | Open → |
| FY20132013-12-31 | $1.1M | −48.3% | Open → |
| FY20122012-12-31 | $2.2M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +23.7%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regenxbio cash |url=https://companiesranked.com/en/company/regenxbio/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regenxbio cash. CompaniesRanked. https://companiesranked.com/en/company/regenxbio/cash-on-handBibTeX
@misc{companiesranked-en-company-regenxbio-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Regenxbio cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regenxbio/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-336725 · August 6, 2026
{{cite web |title=Regenxbio cash — 10-Q (0001193125-26-336725) |url=https://www.sec.gov/Archives/edgar/data/1590877/000119312526336725/rgnx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.